OCUGEN INC. - COMMON STOCK
0.5754
12-March-25 12:32:06
15 minutes delayed
Stocks
+0.0288
+5.27%
Today's range
0.5640 - 0.5845
ISIN
N/A
Source
NASDAQ
-
Ocugen, Inc. Announces Positive DSMB Recommendation for OCU400-101 Clinical Trial
25 Apr 2022 06:33:00 By Nasdaq GlobeNewswire
-
Ocugen, Inc. to Present at NobleCon18
19 Apr 2022 16:32:00 By Nasdaq GlobeNewswire
-
Ocugen, Inc. to Commercialize COVAXIN™ in Mexico, Rights Now Encompassing All of North America
18 Apr 2022 06:11:00 By Nasdaq GlobeNewswire
-
Ocugen, Inc. Provides Update on its Phase 2/3 Study of COVAXIN™ (BBV152)
12 Apr 2022 07:31:00 By Nasdaq GlobeNewswire
-
01 Apr 2022 06:37:00 By Nasdaq GlobeNewswire
-
Ocugen Announces Appointment of Marna C. Whittington, PhD, to Board of Directors
23 Mar 2022 06:44:00 By Nasdaq GlobeNewswire
-
21 Mar 2022 17:36:00 By Nasdaq GlobeNewswire
-
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18 Mar 2022 16:56:00 By Nasdaq GlobeNewswire
-
Ocugen, Inc. to Present at the 34th Annual ROTH Conference
09 Mar 2022 06:11:00 By Nasdaq GlobeNewswire
-
Ocugen Provides an Update on its COVAXIN™ Pediatric (2-18) Emergency Use Authorization (EUA) Request
04 Mar 2022 06:01:00 By Nasdaq GlobeNewswire